Request Your Free White Paper Now:

"Breaking the GLP-1 Cost Cycle: Transforming Access, Cutting Costs, and Shaping the Future of Obesity Care"

As obesity rates rise, GLP-1 medications are gaining popularity. Yet, the multifactorial obesity epidemic presents challenges for organizations as more employees seek GLP-1’s. This white paper explores actionable strategies to help cut costs, improve employee health outcomes, and achieve a measurable ROI.

The cost of obesity is staggering—both in healthcare expenditures and lost productivity. With GLP-1 medications growing in demand, employers are grappling with their high prices, poor medication adherence, and balancing employee health needs with tight budgets.

As an HR leader, you’re uniquely positioned to guide them through these challenges with the right approach. 

This white paper offers actionable strategies to tackle the challenges of obesity care. 

Inside, you’ll find insights on how to:

• Minimize GLP-1 medication costs without sacrificing care quality.
• Combine behavioral and medical interventions for improved outcomes.
• Increase medication adherence to enhance long-term success.
• Deliver measurable ROI with tailored, cost-effective strategies.
• Offer scalable solutions that address diverse workforce needs.

Download now to stay ahead of the curve and create better health outcomes.

Offered Free by: Noom Health
See All Resources from: Noom Health